Theator Palo Alto, Calif.-based the creator of Surgical Intelligence, announced that it has raised $24 million in an extension of its Series A funding round.
This extension follows an initial $15.5M Series A round announced in February 2021, bringing the round total to $39.5M.
The extended funding round was once again led by Insight Partners with support from existing investors including Blumberg Capital, Mayo Clinic, NFX, StageOne Ventures, iAngels, and former Netflix Chief Product Officer Neil Hunt. In addition, new growth investors including iCON and TripActions' CEO and Co-founder Ariel Cohen joined the round.
The additional investment will be used to continue Theator's commercial expansion and accelerate the rollout of its Surgical Intelligence Platform in operating rooms and healthcare systems across North America.
Company: Theator Inc.
Round: Series A
Funding Month: July 2022
Lead Investors: Insight Partners
Additional Investors: Blumberg Capital, Mayo Clinic, NFX, StageOne Ventures, iAngels, Neil Hunt, Icon, Ariel Cohen
Company Website: https://theator.io/
Software Category: Surgical Intelligence platform
About the Company: Theator is pioneering the Surgical Intelligence revolution, harnessing advanced AI and computer vision technology to generate actionable insights which improve the quality of surgical care. By making routine video capture and analysis of the standard of care in surgery, Surgical Intelligence derives never-before-seen-insights to help surgeons and hospital systems understand the causes of variability in patient outcomes and reduce it in the future, while also lowering costs and streamlining procedures in the OR. Theator is partnering with leading surgeons, hospitals, professional societies, and research institutions to create a smarter, more transparent operating room. Based in Palo Alto, California, the company is paving the path for real-time surgical decision support, creating a stronger, healthier world.